IL21 and B-cell chronic lymphocytic leukemia: Although IL-21 serum levels are not found reduced in CLL patients (as compared to healthy controls) (Supplementary Figure 2D), recent studies indicate that promoting the IL-21 production might have a beneficial impact in terms of CLL-cell-directed cytotoxicity [25].